Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 31722-004

9 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 31722-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)
Chemical structure of Venlafaxine Hydrochloride, showing its molecular framework including a chiral center, aromatic ring with a methoxy group, cyclohexane ring, hydroxyl group, and hydrochloride moiety.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot chart showing fold change and 90% confidence intervals for the pharmacokinetics (PK) variables Cmax and AUC of venlafaxine in special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism metabolizers, age over 60 years, and gender differences. The x-axis represents change relative to the reference value with points distributed around 1.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A scatter plot chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine when interacting with various drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole (in CYP2D6 EM's and PM's), Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis shows fold change relative to the reference value, ranging from 0 to 3.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A dot plot chart showing the fold change and 90% confidence intervals of pharmacokinetic values (Cmax and AUC) for various interacting drugs when combined with a reference. Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to the reference value from 0 to 3, illustrating the relative impact on drug concentration and exposure.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxine Hydrochloride 30 Capsules (Venlafaxine Hydrochloride 30 Capsules)

Venlafaxine Hydrochloride 30 Capsules (Venlafaxine Hydrochloride 30 Capsules)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg by Camber Pharmaceuticals, Inc. The label specifies it contains 30 capsules, with instructions for pharmacists to dispense the medication guide to each patient. Storage instructions, a barcode, and manufacturer information including Anora Pharma Pvt. Ltd. in India are also shown.*
FDA Label Image

Venlafaxine Hydrochloride 75mg 30 Capsules (Venlafaxine Hydrochloride 75mg 30 Capsules)

Venlafaxine Hydrochloride 75mg 30 Capsules (Venlafaxine Hydrochloride 75mg 30 Capsules)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg by Camber Pharmaceuticals, Inc. The label indicates the NDC 31722-003-30, package size of 30 capsules, and includes dosage storage instructions, pharmacist dispensing guidance, a barcode, and manufacturer details including Annora Pharma Pvt. Ltd. in India.*
FDA Label Image

Venlafaxine Hydrochloride 150mg 30 Capsules (Venlafaxine Hydrochloride 150mg 30 Capsules)

Venlafaxine Hydrochloride 150mg 30 Capsules (Venlafaxine Hydrochloride 150mg 30 Capsules)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg by Camber Pharmaceuticals, Inc. The label states each capsule contains 150 mg venlafaxine hydrochloride, includes storage instructions (20° to 25°C), a pharmacist dispensing note, a barcode, and contact information. The label is designed for a bottle of 30 capsules and lists the manufacturer as Annora Pharma Pvt. Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.